Brain Tumor Treatments: New York
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: New York
Please scroll down to see the matching trials.
  (0.9416)   Brain Tumor Treatments: New York
  (0.9282)   Map
  (0.8912)   Recently Updated Treatments
  (0.8792)   Glioblastoma Multiforme
  (0.8792)   Glioblastoma Multiforme
  (0.8658)   BORON NEUTRON CAPTURE THERAPY (BNCT)
  (0.8510)   Gliosarcoma
  (0.8351)   Meningioma
  (0.8351)   Brain Tumor Trials And Treatments
  (0.8351)   Brain Tumor Survivor Stories
  (0.8351)   Brain Tumor Trials And Treatments
  (0.8351)   Brain Tumor Trials And Treatments
  (0.8351)   Brain Tumor Trials And Treatments
  (0.8351)   Brain Tumor Trials And Treatments
  (0.8351)   Brain Tumor Trials And Treatments
  (0.8351)   Brain Tumor Trials And Treatments
  (0.8169)   Anaplastic Astrocytoma
  (0.8169)   Anaplastic Astrocytoma
  (0.8169)   Mixed Glioma
  (0.8169)   Medulloblastoma
  (0.8169)   Any Malignant Brain Tumor
  (0.7967)   PNET Tumor
  (0.7967)   Pediatric Brain Tumors
  (0.7967)   Oligodendroglioma Low Grade
  (0.7967)   Oligodendroglioma High Grade
  (0.7967)   Recently Updated Treatments
  (0.7967)   Brainstem Glioma
  (0.7967)   Boron Neutron Capture Therapy
  (0.7967)   RSR-13
  (0.7967)   Advisory Board: Dr. Arno Fried
  (0.7967)   Brain Tumor Survivor Stories
  (0.7967)   Virtualtrials Newsletter
  (0.7967)   Metastatic Brain Tumor
  (0.7967)   Metastatic Brain Tumor
  (0.7967)   Gliadel® Doctors: Alphabetical
  (0.7967)   Brain Tumor Survivor Stories
  (0.7967)   Advanced Search
  (0.7967)   RSR-13
  (0.7967)   RSR-13
  (0.7967)   Ependyoma
  (0.7742)   Malignant Pediatric
  (0.7742)   Brain Tumor Treatments: Radiation
  (0.7742)   Treatment Options For Glioblastomas
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Virtualtrials Newsletter
  (0.7742)   Brain Tumor Organizations
  (0.7742)   Awards and Endorsements
  (0.7742)   Awards and Endorsements
  (0.7742)   Brain Tumor Treatments: Radiation
  (0.7742)   Brain Tumor Activism
  (0.7742)   Letter Writing Wizard
  (0.7742)   Brain Tumor Activism
  (0.7742)   Clinical Trials And Noteworthy Treatments For Brain Tumors: Search for: brain tumor
  (0.7742)   Thalidomide For Brain Tumors
  (0.7742)   High Dose Tamoxifen For Brain Tumors
  (0.7742)   Memorial
  (0.7742)   Brain Tumor Treatments: Less-Toxic
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Temozolomide Update
  (0.7742)   Untitled Document
  (0.7742)   Musella Foundation
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   Brain Tumor Treatments: Surgery
  (0.7742)   Treatment of Hydrocephalus: Shunts
  (0.7742)   Image Guided Surgery
  (0.7742)   Hockey fundraiser
  (0.7742)   Brain Tumor Treatments: Gene Therapy
  (0.7742)   Brain Tumor Treatments: Chemotherapy

Sorry - There were no pages found that contain that search phrase.



  Showing Treatment 1 to 25 of 118 Next 25 Location Last Updated
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) New York, NY USA 09/30/2009
Details Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme New York, NY USA 08/11/2009
Details Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme New York, NY USA 08/11/2009
Details Phase II Clinical Trial of Hyperbaric Oxygenation in Conjunction with Radiotherapy and Temozolomide in Adults with Newly Diagnosed Glioblastoma Mineola, NY USA 06/18/2009
Details Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Oceanside, NY USA 05/20/2009
Details A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas New York, NY USA 04/21/2009
Details Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer Rochester, NY USA 03/15/2009
Details The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme New York, NY USA 03/04/2009
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Syracuse, NY USA 01/31/2009
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Buffalo, NY USA 01/31/2009
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) New York, NY USA 01/31/2009
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) New York, NY USA 01/31/2009
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) New York, NY USA 01/31/2009
Details Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas New York, NY USA 10/27/2008
Details CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan New York, NY USA 10/09/2008
Details Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma New York, NY USA 10/09/2008
Details A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma New York, NY USA 10/09/2008
Details A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer New York, NY USA 07/24/2008
Details Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme New York, NY USA 04/27/2008
Details Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma New York, NY USA 04/15/2008
Details A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas New York, NY USA 04/15/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Syracuse, NY USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Rochester, NY USA 04/11/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Buffalo, NY USA 03/01/2008
Details Gliogene: Brain Tumor Linkage Study New York, NY USA 01/17/2008


Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE
[Click HERE to open a Printer Friendly Version Of This Page!]

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites